Macquarie Group Portfolio holdings
AUM
$81.5B
1-Year Return
21.2%
This Quarter Return
-2.44%
1 Year Return
+21.2%
3 Year Return
+85%
5 Year Return
+166.7%
10 Year Return
+339.95%
AUM
$81.5B
AUM Growth
-$7.54B
(-8.5%)
Cap. Flow
-$4.44B
Cap. Flow
% of AUM
-5.45%
Top 10 Holdings %
Top 10 Hldgs %
11.71%
Holding
2,599
New
31
Increased
604
Reduced
1,360
Closed
377
Top Buys
| 1 |
Netflix
NFLX
|
+$120M |
| 2 |
Aptiv
APTV
|
+$120M |
| 3 |
PayPal
PYPL
|
+$113M |
| 4 |
KLA
KLAC
|
+$87.3M |
| 5 |
HCA Healthcare
HCA
|
+$82.1M |
Top Sells
| 1 |
Mastercard
MA
|
+$216M |
| 2 |
Eli Lilly
LLY
|
+$139M |
| 3 |
GlobalFoundries
GFS
|
+$137M |
| 4 |
Uber
UBER
|
+$134M |
| 5 |
Workday
WDAY
|
+$116M |
Sector Composition
| 1 | Technology | 21.61% |
| 2 | Healthcare | 15.61% |
| 3 | Financials | 13.65% |
| 4 | Industrials | 9.96% |
| 5 | Consumer Discretionary | 9.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1776
Korn Ferry
KFY
$3.81B
| $81K | ﹤0.01% |
1,395
-30,151
| -96% | -$1.75M |
|
1777
Plexus
PLXS
$3.71B
| $81K | ﹤0.01% |
652
-269
| -29% | -$33.4K |
|
1778
BioCryst Pharmaceuticals
BCRX
$1.68B
| $80K | ﹤0.01% |
5,019
-1,302
| -21% | -$20.8K |
|
1779
Strategic Education
STRA
$1.94B
| $80K | ﹤0.01% |
1,240
-55
| -4% | -$3.55K |
|
|
AUD
1780
DELISTED
Audacy, Inc.
AUD
| $80K | ﹤0.01% |
206,300
| – | – |
|
1781
Elanco Animal Health
ELAN
$9.11B
| $79K | ﹤0.01% |
6,338
-20
| -0.3% | -$249 |
|
|
POSH
1782
DELISTED
Poshmark, Inc. Class A Common Stock
POSH
| $79K | ﹤0.01% |
5,047
| – | – |
|
1783
HEICO
HEI
$44.1B
| $79K | ﹤0.01% |
544
-10
| -2% | -$1.45K |
|
1784
Navient
NAVI
$1.29B
| $79K | ﹤0.01% |
4,728
-617
| -12% | -$10.3K |
|
1785
ServisFirst Bancshares
SFBS
$4.6B
| $79K | ﹤0.01% |
480
-509
| -51% | -$83.8K |
|
|
KRTX
1786
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $79K | ﹤0.01% |
124
-227
| -65% | -$145K |
|
|
RUTH
1787
DELISTED
Ruth's Hospitality Group, Inc.
RUTH
| $79K | ﹤0.01% |
3,040
-1,640
| -35% | -$42.6K |
|
1788
Marqeta
MQ
$2.64B
| $78K | ﹤0.01% |
6,852
-457,732
| -99% | -$5.21M |
|
1789
CorVel
CRVL
$4.39B
| $77K | ﹤0.01% |
1,329
-336
| -20% | -$19.5K |
|
1790
PotlatchDeltic
PCH
$3.21B
| $77K | ﹤0.01% |
711
-1,157
| -62% | -$125K |
|
|
RCM
1791
DELISTED
R1 RCM Inc. Common Stock
RCM
| $77K | ﹤0.01% |
2,719
-1,440
| -35% | -$40.8K |
|
|
CCXI
1792
DELISTED
ChemoCentryx, Inc.
CCXI
| $77K | ﹤0.01% |
430
-364
| -46% | -$65.2K |
|
1793
APi Group
APG
$14.6B
| $76K | ﹤0.01% |
7,305
-2,156
| -23% | -$22.4K |
|
1794
Herbalife
HLF
$958M
| $76K | ﹤0.01% |
1,714
-2,106
| -55% | -$93.4K |
|
1795
Strategy Inc Common Stock Class A
MSTR
$92.6B
| $76K | ﹤0.01% |
2,370
-1,200
| -34% | -$38.5K |
|
1796
TripAdvisor
TRIP
$2.06B
| $76K | ﹤0.01% |
2,509
-3,480
| -58% | -$105K |
|
|
DCPH
1797
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $76K | ﹤0.01% |
3,862
-261
| -6% | -$5.14K |
|
1798
Kulicke & Soffa
KLIC
$1.98B
| $74K | ﹤0.01% |
813
-1,096
| -57% | -$99.8K |
|
|
AMED
1799
DELISTED
Amedisys
AMED
| $73K | ﹤0.01% |
431
-328
| -43% | -$55.6K |
|
1800
Corcept Therapeutics
CORT
$7.55B
| $73K | ﹤0.01% |
1,146
-1,716
| -60% | -$109K |
|